Publication|Articles|July 8, 2024
Supplements and Featured Publications
- Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Advertisement
This clinical brief provides a background on DED and reviews DED treatment and challenges associated with prescription eye drops.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
Anti-Inflammatory, Antioxidant-Rich Diets May Lower Skin Cancer Risk, Slow Biological Aging
3
5 FAQs About ICHRAs: What to Know as ACA Subsidy Extensions Stall
4
Long-Term CR Seen With Allo-CAR-NK Cell Therapy Plus Rituximab in Waldenstrom NHL
5
























































